OncoTricks

Tubules, cold proteins and confusion, Oct 14, 2026

Ifosfamide and the leaking tubule

If you remember one thingPotassium, phosphate and magnesium that will not hold, a normal anion gap acidosis and a normal creatinine: that is the proximal tubule leaking, not someone forgetting the replacement. Magnesium first, then potassium and phosphate, alkali last and only when potassium and calcium are safe.

Why it happens

Ifosfamide→Chloroacetaldehyde made inside the tubule cell→Proximal tubule stops reabsorbing→Phosphate, potassium, bicarbonate, glucose, amino acids, uric acid lost in urine

That is the Fanconi syndrome. Magnesium is lost too. The glomerular filtration rate can stay normal, so the creatinine does not warn you. Cyclophosphamide, the sister drug, makes little of this metabolite and almost never does this. Mesna protects the bladder, not the tubule. The same metabolite causes ifosfamide encephalopathy.

Recognize it on the morning labs

BloodLow potassium, phosphate, magnesium.
Low bicarbonate with a normal anion gap.
Low uric acid (the opposite of tumor lysis).
Creatinine often normal.
UrineGlucose in the urine with a normal blood glucose.
Phosphate and magnesium still being excreted despite low blood levels: fractional excretion of phosphate above 5% when the serum phosphate is low (or a low TmP/GFR).
Urine pH is usually acid (below 5.5) once the serum bicarbonate has fallen; it turns alkaline when you give bicarbonate, because the tubule spills it. A low urine pH does not exclude this.
WhoCumulative dose is the main risk.
Prior cisplatin, a single or damaged kidney, young age in some series.
Can appear during the course or months after it.
Moderate or severe nephrotoxicity by cumulative ifosfamide dose, 23 children (Skinner 1996)
Under 100 g/m2
2 of 10
100 g/m2 or more
6 of 10
Only total dose predicted tubular toxicity in that cohort. Lymphoma salvage rarely gets near this: an ICE cycle is 5 g/m2 and most patients get two or three. Sarcoma regimens give 9 to 14 g/m2 per cycle, so six cycles reach 54 to 84 g/m2, which is where the pediatric data put the risk (Skinner 2000 saw a sharp rise above 84 g/m2).

In adults the full syndrome is uncommon; partial tubular wasting is not.In a prospective cohort of children and young adults with sarcoma on high-dose ifosfamide, 4% developed a Fanconi-like syndrome, but every patient had a measurable, reversible tubular leak after each cycle (Ho 1995). Adult series are smaller and the full syndrome is uncommon; partial wasting is the rule. In children, moderate or severe nephrotoxicity is reported in about 28% (Skinner 2000), with rickets in the severe cases.

Replace in this order

1. Magnesium low?
yes
Magnesium firstLow magnesium makes the kidney waste potassium and blocks parathyroid hormone release. Potassium and calcium will not hold until magnesium is corrected.
then
2. Potassium and phosphate
replace
Potassium phosphate covers bothCheck twice a day while wasting is active. Potassium phosphate carries 4.4 mEq of potassium per mmol of phosphate, so the infusion rate is limited by the potassium, not the phosphate. If calcium is very low, raise it before giving IV phosphate: phosphate binds calcium and drops it further.
then
3. Calcium low?
yes
Correct calcium before alkaliIonized calcium and an ECG (QT interval). Correct the total calcium for albumin, or better, measure the ionized value.
calcium safe
4. Now treat the acidosisBicarbonate, or potassium citrate, which gives alkali and potassium together. Alkali lowers potassium twice over (cellular shift, and more bicarbonate in the distal tubule means more potassium wasting), so potassium must be replete before and during it; potassium citrate solves both. Proximal RTA needs large doses and the wasting gets worse as you raise the serum bicarbonate.
Bicarbonate with a low calcium→Ionized calcium falls further: tetany, seizures, arrhythmia

Alkali raises the pH, more calcium binds to albumin, and the free (ionized) fraction drops. The same reason hyperventilating patients get tingling. The cue: Mag, then K and phos, then calcium, alkali last.

Next steps

1
Nephrology early. Fractional excretion of phosphate and magnesium, urine glucose and amino acids confirm the diagnosis.
2
Tell the disease team. Further ifosfamide is a judgment of benefit against a tubule that may not recover. Some teams switch to cyclophosphamide where the regimen allows.
3
Follow after treatment. Some patients need oral phosphate and alkali for months or years; untreated phosphate loss softens bone.
Sources

Retrieved from PubMed, read on Oct 15, 2026.

  1. Skinner R, et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996. doi:10.1016/s0140-6736(96)03480-0
  2. Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer 2000. doi:10.1054/bjoc.2000.1214
  3. Ho PT, et al. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer 1995.doi:10.1002/1097-0142(19951215)76:12<2557::aid-cncr2820761223>3.0.co;2-9
  4. Hanly L, et al. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. Expert Opin Drug Saf 2009. doi:10.1517/14740330902808169
  5. Quiroz-Aldave JE, et al. Ifosfamide-induced nephrotoxicity in oncological patients. Expert Rev Anticancer Ther 2024. doi:10.1080/14737140.2023.2290196